Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Pride 2024: How can pharma leaders make a difference?
Hear from four pharma leaders on the benefits to employees and patients of workplaces that promote inclusivity for the LGBTQ+ community.
Read more
Reframing pharma's bad boy reputation
The pharmaceutical industry is a rich source of material for the small screen, but why is it framed as the perpetual bad boy?
Sanofi’s Dr Juby Jacob-Nara on medical affairs and mentorship
How does a physician make a difference in medical affairs? Juby Jacob-Nara tells her story.
Pharma's next move in the online jungle
What lies in wait for pharma in the social media jungle?
Bolstering data ownership with blockchain
Blockchain allow patients to own their data and better protects their personal information. How could it change the data landscape in pharma?
Pharma in India
India, known by some as ‘the pharmacy of the world’, has a growing pharma reputation, but what has shaped this company’s ascension to pharmaceutical powerhouse status?
Are MSLs ready for the spotlight?
How can the industry empower MSLs as they do sales reps?
The Sunshine Rule: 5 years on
The Sunshine Rule swept away the clouds that cast shade over the pharmaceutical industry’s interactions with its customers, but what has been its impact five years on?
Sanofi Genzyme’s Bill Sibold on preventing future health inequities
Sanofi’s Bill Sibold shares his tips on reducing time to market for pharmaceutical drugs, public perceptions of the industry after COVID-19 and more.
Loading posts...
« Previous
1
…
11
12
13
14
15
…
30
Next »